G Cediel1, C Corvalán1, C Aguirre1, D L de Romaña1,2, R Uauy1,3. 1. Institute of Nutrition and Food Technology, University of Chile, Santiago, Chile. 2. Nutrition Research Institute, Lima, Peru. 3. Department of Nutrition and Public Health Intervention Research, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Abstract
BACKGROUND: Consistent data on the relation between vitamin D, body fat and insulin resistance (IR) in children are lacking. OBJECTIVES: (1) To evaluate the association between serum 25-Hydroxyvitamin D [25(OH)D] and key indicators of: adiposity (total and central), IR, and (2) to estimate serum 25(OH)D cut-offs that best reflect IR and total and central adiposity in children. SUBJECTS/ METHODS: Prepubertal children (n=435, ~53% girls; ~age 7 years) from the Growth and Obesity Chilean Cohort Study were evaluated for potential associations between serum 25(OH)D and indicators of: (1) total adiposity (body mass index by age (BAZ), body fat (including three-component model)), central adiposity (waist circumference and trunk fatness); (2) IR (homeostasis model assessment of IR) and insulin sensitive (quantitative insulin sensitivity check index) using standardized multiple regression models with standardized coefficients and receiver operating characteristic curves. RESULTS: Overall, mean serum 25(OH)D was 32.1±9.2 ng ml(-1), while 19.4% of children were obese (BAZ⩾2 s.d.). Serum 25(OH)D was inversely associated with indicators of total and central adiposity and with IR indicators. Effect sizes were moderate in girls (~0.3 for adiposity and IR indicators), while, weaker values were found in boys. Serum 25(OH)D estimated cut-offs that best predicted total, central adiposity and IR were~30 ng ml(-1). Children with suboptimal serum 25(OH)D (<30 ng ml(-1)) had a higher risk (two to three times) of being obese (high BAZ, body fat percent and/or central adiposity); and three to four times greater risk for IR. CONCLUSIONS: Serum 25(OH)D was inversely associated with adiposity (total and central) and IR indicators in prepubertal Chilean children. The conventional cut-off of vitamin D sufficiency (⩾30 ng ml(-1)) was adequate to assess obesity and IR risk in this age group.
BACKGROUND: Consistent data on the relation between vitamin D, body fat and insulin resistance (IR) in children are lacking. OBJECTIVES: (1) To evaluate the association between serum 25-Hydroxyvitamin D [25(OH)D] and key indicators of: adiposity (total and central), IR, and (2) to estimate serum 25(OH)D cut-offs that best reflect IR and total and central adiposity in children. SUBJECTS/ METHODS: Prepubertal children (n=435, ~53% girls; ~age 7 years) from the Growth and Obesity Chilean Cohort Study were evaluated for potential associations between serum 25(OH)D and indicators of: (1) total adiposity (body mass index by age (BAZ), body fat (including three-component model)), central adiposity (waist circumference and trunk fatness); (2) IR (homeostasis model assessment of IR) and insulin sensitive (quantitative insulin sensitivity check index) using standardized multiple regression models with standardized coefficients and receiver operating characteristic curves. RESULTS: Overall, mean serum 25(OH)D was 32.1±9.2 ng ml(-1), while 19.4% of children were obese (BAZ⩾2 s.d.). Serum 25(OH)D was inversely associated with indicators of total and central adiposity and with IR indicators. Effect sizes were moderate in girls (~0.3 for adiposity and IR indicators), while, weaker values were found in boys. Serum 25(OH)D estimated cut-offs that best predicted total, central adiposity and IR were~30 ng ml(-1). Children with suboptimal serum 25(OH)D (<30 ng ml(-1)) had a higher risk (two to three times) of being obese (high BAZ, body fat percent and/or central adiposity); and three to four times greater risk for IR. CONCLUSIONS: Serum 25(OH)D was inversely associated with adiposity (total and central) and IR indicators in prepubertal Chilean children. The conventional cut-off of vitamin D sufficiency (⩾30 ng ml(-1)) was adequate to assess obesity and IR risk in this age group.
Authors: Renata M S Oliveira; Juliana F Novaes; Luiza M Azeredo; Lorena M Azeredo; Ana Paula C Cândido; Isabel C G Leite Journal: Public Health Nutr Date: 2013-05-09 Impact factor: 4.022
Authors: L Wamberg; T Christiansen; S K Paulsen; S Fisker; P Rask; L Rejnmark; B Richelsen; S B Pedersen Journal: Int J Obes (Lond) Date: 2012-07-17 Impact factor: 5.095
Authors: Leticia Elizondo-Montemayor; Patricia A Ugalde-Casas; Mónica Serrano-González; Carlos A Cuello-García; José R Borbolla-Escoboza Journal: Obesity (Silver Spring) Date: 2009-12-10 Impact factor: 5.002
Authors: Alexandra M Binder; Camila Corvalan; Verónica Mericq; Ana Pereira; José Luis Santos; Steve Horvath; John Shepherd; Karin B Michels Journal: Epigenetics Date: 2018-02-15 Impact factor: 4.528
Authors: Benjamin I Perry; Hannah J Jones; Tom G Richardson; Stan Zammit; Nicholas J Wareham; Glyn Lewis; Peter B Jones; Golam M Khandaker Journal: Schizophr Res Date: 2020-08-19 Impact factor: 4.939
Authors: Lara S Yoon; Jonathan P Jacobs; Jessica Hoehner; Ana Pereira; Juan Cristóbal Gana; Camila Corvalán; Karin B Michels Journal: Front Cell Infect Microbiol Date: 2021-12-17 Impact factor: 5.293
Authors: Alexandra M Binder; Leah T Stiemsma; Kristen Keller; Sanne D van Otterdijk; Verónica Mericq; Ana Pereira; José L Santos; John Shepherd; Karin B Michels Journal: Clin Epigenetics Date: 2018-10-04 Impact factor: 6.551
Authors: Karin B Michels; Kristen Keller; Ana Pereira; Claire E Kim; José L Santos; John Shepherd; Camila Corvalan; Alexandra M Binder Journal: Breast Cancer Res Date: 2020-10-01 Impact factor: 6.466